Aureus Asset Management LLC Acquires New Position in Agilent Technologies, Inc. $A

Aureus Asset Management LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 1st quarter, Holdings Channel.com reports. The fund bought 28,667 shares of the medical research company’s stock, valued at approximately $3,267,000.

A number of other large investors have also modified their holdings of A. Norges Bank purchased a new position in Agilent Technologies in the fourth quarter worth $549,158,000. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. AQR Capital Management LLC grew its stake in shares of Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. increased its holdings in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Finally, Balyasny Asset Management L.P. increased its holdings in shares of Agilent Technologies by 192.0% in the 4th quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock valued at $192,204,000 after purchasing an additional 928,821 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of A opened at $133.49 on Thursday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a market cap of $37.70 billion, a P/E ratio of 26.81, a PEG ratio of 2.36 and a beta of 1.25. The company has a 50-day moving average of $128.68 and a two-hundred day moving average of $125.45. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 6.01 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. Jefferies Financial Group began coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective on the stock. Robert W. Baird increased their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price target for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Barclays boosted their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 24th. Finally, HSBC dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.